Guardion Health Sciences, which sells medical food and devices for retinal diseases, announced terms for its IPO on Monday.
The San Diego, CA-based company plans to raise $9 million by offering 2.5 million shares at a price range of $3 to $4. At the midpoint of the proposed range, Guardion Health Sciences would command a fully diluted market value of $84 million.
Guardion Health Sciences was founded in 2009 and booked $1 million in revenue for the 12 months ended September 30, 2018. It plans to list on the NYSE under the symbol GHSI. WallachBeth Capital is the sole bookrunner on the deal.
